当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Nitroglycerin Repak
HUMAN COMPOUNDED DRUG
61141-4834
Medi-Fare Drug
2021/2/1 0:00:00
NITROGLYCERIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 ug/1 mL
61141-4834-1
Ropivacaine HCl
HUMAN COMPOUNDED DRUG
61141-1370
Medi-Fare Drug
2021/2/1 0:00:00
ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
61141-1370-5
Iopamidol 41% Repak
HUMAN COMPOUNDED DRUG
61141-1326
Medi-Fare Drug
2021/2/1 0:00:00
IOPAMIDOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
408 mg/1 mL
61141-1326-1
Proparacaine HCl Repak
HUMAN COMPOUNDED DRUG
61141-4536
Medi-Fare Drug
2021/2/1 0:00:00
PROPARACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5 mg/1 mL
61141-4536-4
Esmolol HCl
HUMAN COMPOUNDED DRUG
61141-1367
Medi-Fare Drug
2021/2/1 0:00:00
ESMOLOL HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
61141-1367-5
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
61141-1351
Medi-Fare Drug
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
61141-1351-1
Ephedrine Sulfate
HUMAN COMPOUNDED DRUG
61141-1350
Medi-Fare Drug
2021/2/1 0:00:00
EPHEDRINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg/1 mL
61141-1350-5
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
61141-1418
Medi-Fare Drug
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 ug/1 mL
61141-1418-1
Azelaic Acid/Niacinamide/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3107
Empower Pharmacy
2021/2/1 0:00:00
AZELAIC ACID; NIACINAMIDE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/1 g; 40 mg/1 g; .3 mg/1 g
72627-3107-1
Niacinamide/Tretinoin
HUMAN COMPOUNDED DRUG
72627-3151
Empower Pharmacy
2021/2/1 0:00:00
NIACINAMIDE; TRETINOIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 mg/1 g; .5 mg/1 g
72627-3151-1
PROGESTERONE SA2 100MG
HUMAN COMPOUNDED DRUG
70713-026
Wells Pharmacy, Inc
2022/1/1 0:00:00
PROGESTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg
70713-026-01
TESTOSTERONE SA2 50MG
HUMAN COMPOUNDED DRUG
70713-004
Wells Pharmacy, Inc
2022/1/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg
70713-004-01
TESTOSTERONE C 87.5MG
HUMAN COMPOUNDED DRUG
70713-045
Wells Pharmacy, Inc
2022/1/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
80 mg
70713-045-01
ESTRADIOL 18MG
HUMAN COMPOUNDED DRUG
70713-144
Wells Pharmacy, Inc
2022/1/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
18 mg
70713-144-01
Memorial Hermann Formula
HUMAN COMPOUNDED DRUG
72196-0216
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
SODIUM CHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; CALCIUM CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
110 meq/1018 mL; 32.074 meq/1018 mL; 40 meq/1018 mL; 420 mg/1018 mL; 3.808 meq/1018 mL
72196-0216-1
Trophamine 3% / Dextrose 10% 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
72196-0404
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
PHENYLALANINE; TRYPTOPHAN; VALINE; GLUTAMIC ACID; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.36 g/250 mL; .15 g/250 mL; .585 g/250 mL; .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL
72196-0404-1
ESTRADIOL 10MG
HUMAN COMPOUNDED DRUG
70713-056
Wells Pharmacy, Inc
2022/1/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg
70713-056-01
ESTRADIOL 25MG
HUMAN COMPOUNDED DRUG
70713-053
Wells Pharmacy, Inc
2022/1/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
25 mg
70713-053-01
TESTOSTERONE 50 MG
HUMAN COMPOUNDED DRUG
73693-387
FARMAKEIO OUTSOURCING LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg
73693-387-01
TESTOSTERONE 37.5 MG
HUMAN COMPOUNDED DRUG
73693-388
FARMAKEIO OUTSOURCING LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
37.5 mg
73693-388-01
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3